Geode Capital Management, LLC Gt Biopharma, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.24 - $0.35 $27,329 - $39,854	113,871 Added 50.96%	337,315 $80,000
Q4 2022 Feb 13, 2023	SELL	$0.89 - $58.2 $412 - $27,004	-464 Reduced 0.21%	223,444 $199,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $56.1 $78,546 - $2.43 Million	-43,396 Reduced 16.23%	223,908 $394,000
Q2 2022 Aug 12, 2022	SELL	$1.64 - $3.11 $155,980 - $295,792	-95,110 Reduced 26.24%	267,304 $799,000
Q1 2022 May 13, 2022	SELL	$2.6 - $3.3 $66,388 - $84,262	-25,534 Reduced 6.58%	362,414 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$3.05 - $7.08 $110,809 - $257,223	-36,331 Reduced 8.56%	387,948 $1.18 Million
Q3 2021 Nov 12, 2021	BUY	$6.68 - $15.26 $518,855 - $1.19 Million	77,673 Added 22.41%	424,279 $2.86 Million
Q2 2021 Aug 13, 2021	BUY	$7.19 - $18.96 $1.55 Million - $4.1 Million	216,218 Added 165.83%	346,606 $5.37 Million
Q1 2021 May 12, 2021	BUY	$4.4 - $8.84 $573,707 - $1.15 Million	130,388 New	130,388 $891,000

564

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.